Neurotoxic phospholipase A2 toxicity model : an insight from mammalian cells
Vardjan, Nina and Mattiazzi, Mojca and Rowan, Edward G. and Križaj, Igor and Petrovič, Uros̀ and Petan, Toni (2013) Neurotoxic phospholipase A2 toxicity model : an insight from mammalian cells. Communicative and Integrative Biology, 6 (3). e23600. ISSN 1942-0889 (https://doi.org/10.4161/cib.23600)
Preview |
Text.
Filename: Vardjan_etal_CIB_2013_Neurotoxic_phospholipase_A2_toxicity_model.pdf
Final Published Version License: Download (427kB)| Preview |
Abstract
The molecular mechanism of action of presynaptically neurotoxic secreted phospholipases A2 (sPLA2s) has not been fully elucidated. We have recently proposed a model to explain one of the hallmarks of their action - the reduction in endocytosis leading to synaptic vesicle depletion in nerve terminals. Our results speak strongly in favor of a mechanism in which both specific protein-protein interactions and enzymatic activity of the neurotoxic sPLA2 ammodytoxin A (AtxA) are necessary for impairment of clathrin-dependent endocytosis in yeast cells. The reduction of endocytosis was strictly dependent on the enzymatic activity of sPLA2s expressed ectopically in our yeast model cells and was not observedwith the catalytically inactive, non-neurotoxic AtxA-homolog, ammodytin L (AtnL). Here weconfirm the validity of the model in mammalian cells also, by demonstrating that the enzymatically active mutant of AtnL, shown to inhibit endocytosis in yeast, acts as a presynaptically neurotoxic sPLA2 at the mammalian neuromuscular junction.
-
-
Item type: Article ID code: 63197 Dates: DateEvent9 April 2013Published14 January 2013AcceptedSubjects: Medicine > Pharmacy and materia medica
Science > MicrobiologyDepartment: Faculty of Science > Strathclyde Institute of Pharmacy and Biomedical Sciences Depositing user: Pure Administrator Date deposited: 06 Feb 2018 15:53 Last modified: 11 Nov 2024 11:55 Related URLs: URI: https://strathprints.strath.ac.uk/id/eprint/63197